The Development of HLAnull K562 Cells Expressing CD1d and Co-Stimulatory Molecules as Artificial Antigen-Presenting Cells for Clinical Scale Expansion of NKT Cells With Superior In Vivo Persistence and Anti-Tumor Potential

MOLECULAR THERAPY

卷 23, 期 -, 页码 S162-S162

NATURE PUBLISHING GROUP

-

Biotechnology & Applied Microbiology Genetics & Heredity Medicine, Research & Experimental